Effects of photodynamic therapy in combination with intravesical drugs in a murine bladder tumor model.

This study was designed to evaluate the interaction of photodynamic therapy (PDT) and intravesical drugs (thiotepa, adriamycin, mitomycin C and BCG) in a murine transitional cell carcinoma (MBT-2) model. C3H/He mice with implanted MBT-2 flank tumors were treated with either thiotepa (TT), adriamycin (ADM), mitomycin C, Bacillus Calmette-Guerin (BCG), photodynamic therapy (PDT) or a combination of the drug and PDT. The MBT-2 tumor showed sensitivity to adriamycin, MMC or PDT compared to control. PDT combined with either adriamycin, MMC or BCG, produced a greater retardation in the growth of the MBT-2 tumor than monotherapy with adriamycin, MMC, BCG or PDT. PDT combined with the anticancer agents currently used in intravesical therapy for bladder cancer is well tolerated. The combination of PDT and intravesical drugs may enhance the tumoricidal effect of either treatment used alone.

[1]  D. Kessel.  PROPOSED STRUCTURE OF THE TUMOR‐LOCALIZING FRACTION OF HPD (HEMATOPORPHYRIN DERIVATIVE) , 1986, Photochemistry and photobiology.

[2]  G. Hahn.  Potential for therapy of drugs and hyperthermia. , 1979, Cancer research.

[3]  Morton Dl.  Horizons in tumor immunology. , 1973 .

[4]  D S Zaharko,et al.  Modification of chemotherapeutic effects on L1210 cells using hematoporphyrin and light. , 1983, Cancer research.

[5]  A. Pang,et al.  Immunoprophylaxis of a murine bladder cancer with high dose BCG immunizations. , 1982, The Journal of urology.

[6]  M. Soloway.  Intravesical and systemic chemotherapy of murine bladder cancer. , 1977, Cancer research.

[7]  K. Burnand,et al.  Single dose intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder carcinoma. , 1976, British journal of urology.

[8]  D. Byar,et al.  Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer. , 1977, Urology.

[9]  D. Lamm,et al.  Immunotherapy of murine transitional cell carcinoma. , 1982, The Journal of urology.

[10]  T J Dougherty,et al.  Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor. , 1976, Cancer research.

[11]  RN J.H. Coffey,et al.  Evaluation of visual acuity during laser photoradiation therapy of cancer , 1984, Lasers in surgery and medicine.

[12]  M W Berns,et al.  Laser photoradiation therapy of cancer: Possible role of hyperthermia , 1984, Lasers in surgery and medicine.

[13]  M. Berns,et al.  Combination cytotoxic chemotherapy with cisplatin or doxorubicin and photodynamic therapy in murine tumors. , 1988, Journal of the National Cancer Institute.

[14]  P A Cowled,et al.  Pharmacological modulation of photodynamic therapy with hematoporphyrin derivative and light. , 1987, Cancer research.

[15]  R. Herberman,et al.  Natural cell-mediated immunity. , 1978, Advances in cancer research.